IDEXX Laboratories trades as part of the healthcare sector and trades as part of the medical diagnostics and research industry. The company CEO is Jonathan W. Ayers. IDEXX Laboratories Inc develops, manufactures and distributes products and provide services for companion animal veterinary, livestock and poultry, dairy and water testing markets.
Previous Intraday Trading Performance:
The IDXX stock showed a previous change of 1.00% with an open at 254.47 and a close of 256.11. It reached an intraday high of 258.42 and a low of 254.47.
The stock has a market cap of $22.0b with 86.0m shares outstanding, of which the float is 84.4m shares. Trading volume reached 372,160 shares compared to its average volume of 471,961 shares. Based on the current average volume and close price, the trading liquidity is good.
Historical Trading Performance:
Over the last five trading days, IDEXX Laboratories shares returned 3.05% and in the past 30 trading days it returned 13.67%. Over three months, it changed 21.90%. In one year it has changed 26.56% and within that year its 52-week high was 258.42 and its 52-week low was 176.11. IDXX stock is 45.43% above its 52 Week Low.
Our calculations show a 200 day moving average of 219.59 and a 50 day moving average of 232.22. Currently IDXX stock is trading 16.63% above its 200 day moving average.
The last annual fiscal EPS for the company was reported at 4.26 that ended on 31st of December 2018, which according to the previous close, that is a PE of 60.12. Based on 4 analyst estimates, the consensus EPS for the next quarter is 1.04. The TTM EPS is 4.27, which comes to a TTM PE of 59.98. Historically, the PE high was 87.10 and the PE low was 30.10. If the stock reached its PE low, that would represent a price of 128.52, which is a decrease of -49.82%.
Below was the last reported quarterly diluted earnings per share:
|1st||Qtr of 2019||1.17|
|4th||Qtr of 2018||0.98|
|3rd||Qtr of 2018||1.05|
|2nd||Qtr of 2018||1.23|
|1st||Qtr of 2018||1.01|
Base on our calculations, the intrinsic value per share is 112.86, which means it may be overvalued by -126.92%.
Indicators to Watch:
The current calculated beta is 0.88.
SeekingAlpha: HP Inc. 2019 Q2 – Results – Earnings Call Slides
Based on last reported financials, the company’s return on equity is 34,083.93%, return on assets is 24.77%, profit margin is 17.33%, price-to-sales is 9.69 and price-to-book is 427.20.
All scores are out of six:
0 :Valuation Score
4 :Past Performance Score
3 :Financial Strength Score
2 :Future Growth Score
0 :Dividend Score
2 :Overall Score